Myotonic syndromes

Current Opinion in Neurology

Volumn 15, Issue 5, 2002, Pages 545-552

  Mankodi, Ami ^a   Thornton, Charles A ^a,b  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

^b UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

Myotonia; Myotonic dystrophy; Nuclear inclusions; PROMM; Triplet repeat disease

Indexed keywords

CHLORIDE; CHLORIDE CHANNEL; DNA; GENE PRODUCT; PROTEIN KINASE; RNA; SODIUM CHANNEL; SODIUM ION;

ALLELE; CLINICAL FEATURE; DIFFERENTIAL DIAGNOSIS; DMPK GENE; GENE IDENTIFICATION; GENE MUTATION; HUMAN; MOLECULAR GENETICS; MYOTONIA; MYOTONIC DYSTROPHY; REVIEW; RNA ANALYSIS; RNA PROCESSING; SYNDROME DELINEATION;

ALLELES; ALTERNATIVE SPLICING; ANIMALS; CHLORIDE CHANNELS; HUMANS; MUTATION; MYOTONIC DISORDERS; MYOTONIC DYSTROPHY; PROTEIN-SERINE-THREONINE KINASES; RNA-BINDING PROTEINS; SODIUM CHANNELS; TRINUCLEOTIDE REPEAT EXPANSION;

EID: 0036797865     PISSN: 13507540     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019052-200210000-00005     Document Type: Review

References (64)

1. Harper PS. Myotonic dystrophy. London: WB Saunders Company; 2001.
2. Ashizawa T. International Myotonic Dystrophy Consortium. New nomenclature and DNA testing guidelines for myotonic dystrophy type 1 (DM1). Neurology 2000; 54:1218-1221.
3. Brook JD, McCurrach ME, Harley HG, et al. Molecular basis of myotonic dystrophy: expansion of a trinucleotide (CTG) repeat at the 3′ end of a transcript encoding a protein kinase family member. Cell 1992; 68:799-808.
4. Liquori CL, Ricker K, Moseley ML, et al. Myotonic dystrophy type 2 caused by a CCTG expansion in intron 1 of ZNF9. Science 2001; 293:864-867.
5. Jansen G, Willems P, Coerwinkel M, et al. Gonosomal mosaicism in myotonic dystrophy patients: involvement of mitotic events in (CTG)n repeat variation and selection against extreme expansion in sperm. Am J Hum Genet 1994; 54:575-585.
6. Zeesman S, Carson N, Whelan DT. Paternal transmission of the congenital form of myotonic dystrophy type 1: a new case and review of the literature. Am J Med Genet 2002; 107:222-226.
7. Amiel J, Raclin V, Jouannic JM, et al. Trinucleotide repeat contraction: a pitfall in prenatal diagnosis of myotonic dystrophy. J Med Genet 2001; 38:850-852.
8. de Die-Smulders CE, Howeler CJ, Thijs C, et al. Age and causes of death in adult·onset myotonic dystrophy. Brain 1998; 121:1557-1563.
9. Clarke NR, Kelion AD, Nixon J, et al. Does cytosine-thymine-guanine (CTG) expansion size predict cardiac events and electrocardiographic progression in myotonic dystrophy? Heart 2001; 86:411-416.
10. Thornton CA, Johnson K, Moxley RT. Myotonic dystrophy patients have larger CTG expansions in skeletal muscle than in leukocytes. Ann Neurol 1994; 35:104-107.
11. Wong LJ, Ashizawa T, Monckton DG, et al. Somatic heterogeneity of the CTG repeat in myotonic dystrophy is age and size dependent. Am J Hum Genet 1995; 56:114-122.
12. Martorell L, Monckton DG, Gamez J, et al. Progression of somatic CTG repeat length heterogeneity in the blood cells of myotonic dystrophy patients. Hum Mol Genet 1998; 7:307-312.
13. Pearson CE, Ewel A, Acharya S, et al. Human MSH2 binds to trinucleotide repeat DNA structures associated with neurodegenerative diseases. Hum Mol Genet 1997; 6:1117-1123.
14. van Den Broek WJ, Nelen MR, Wansink DG, et al. Somatic expansion behaviour of the (CTG)(n) repeat in myotonic dystrophy knock-in mice is differentially affected by Msh3 and Msh6 mismatch-repair proteins. Hum Mol Genet 2002; 11:191-198.
15. Kovtun IV, McMurray CT. Trinucleotide expansion in haploid germ cells by gap repair. Nat Genet 2001; 27:407-411.
16. Zatz M, Passos-Bueno MR, Cerqueira A, et al. Analysis of the CTG repeat in skeletal muscle of young and adult myotonic dystrophy patients: when does the expansion occur? Hum Mol Genet 1995; 4:401-406.
17. Muranyi A, Zhang R, Liu F, et al. Myotonic dystrophy protein kinase phosphorylates the myosin phosphatase targeting subunit and inhibits myosin phosphatase activity. FEBS Lett 2001; 493:80-84.
18. Shimizu M, Wang W, Walch ET, et al. Rac-1 and Raf-1 kinases, components of distinct signaling pathways, activate myotonic dystrophy protein kinase. FEBS Lett 2000; 475:273-277.
19. Benders AA, Groenen PJ, Oerlemans FT, et al. Myotonic dystrophy protein kinase is involved in the modulation of the Ca2+ homeostasis in skeletal muscle cells. J Clin Invest 1997; 100:1440-1447.
20. Otten AD, Tapscott SJ. Triplet repeat expansion in myotonic dystrophy alters the adjacent chromatin structure. Proc Natl Acad Sci USA 1995; 92:5465-5469.
21. Klesert TR, Otten AD, Bird TD, Tapscott SJ. Trinucleotide repeat expansion at the myotonic dystrophy locus reduces expression of the DMAHP gene. Nat Genet 1997; 16:402-406.
22. Thornton CA, Wymer JP, Simmons Z, et al. Expansion of the myotonic dystrophy CTG repeat reduces expression of the flanking DMAHP gene. Nat Genet 1997; 16:407-409.
23. Klesert TR, Cho DH, Clark JI, et al. Mice deficient in Six5 develop cataracts: implications for myotonic dystrophy. Nat Genet 2000; 25:105-109.
24. Sarkar PS, Appukuttan B, Han J, et al. Heterozygous loss of Six5 in mice is sufficient to cause ocular cataracts. Nat Genet 2000; 25:110-114.
25. Filippova GN, Thienes CP, Penn BH, et al. CTCF-binding sites flank CTG/CAG repeats and form a methylation-sensitive insulator at the DM1 locus. Nat Genet 2001; 28:335-343.
26. Taneja KL, McCurrach M, Schalling M, et al. Foci of trinucleotide repeat transcripts in nuclei of myotonic dystrophy cells and tissues. J Cell Biol 1995; 128:995-1002.
27. Davis BM, McCurrach ME, Taneja KL, et al. Expansion of a CUG trinucleotide repeat in the 3′ untranslated region of myotonic dystrophy protein kinase transcripts results in nuclear retention of transcripts. Proc Natl Acad Sci USA 1997;94:7388-7393.
28. Berul CI, Maguire CT, Gehrmann J, Reddy S. Progressive atrioventricular conduction block in a mouse myotonic dystrophy model. J Intervent Cardiac Electrophysiol 2000; 4:351-358.
29. Reddy S, Smith DBJ, Rich MM, et al. Mice lacking the myotonic dystrophy protein kinase develop a late onset progressive myopathy. Nat Genet 1996; 13:325-334.
30. Jansen G, Groenen PJTA, Bachner D, et al. Abnormal myotonic dystrophy protein kinase levels produce only mild myopathy in mice. Nat Genet 1996; 13:316-324.
31. Mankodi A, Logigian E, Callahan L, et al. Myotonic dystrophy in transgenic mice expressing an expanded CUG repeat. Science 2000; 289:1769-1773.
32. Seznec H, Agbulut O, Sergeant N, et al. Mice transgenic for the human myotonic dystrophy region with expanded CTG repeats display muscular and brain abnormalities. Hum Mol Genet 2001; 10:2717-2726.
33. Napierala M, Krzyzosiak WJ. CUG repeats present in myotonin kinase RNA form metastable slippery hairpins. J Biol Chem 1997; 272:31079-31085.
34. Tian B, White R, Xia T, et al. Expanded CUG repeat RNAs form hairpins that activate the double-stranded RNA-dependent protein kinase PKR. RNA 2000; 6:79-87.
35. Timchenko LT, Miller JW, Timchenko NAXDD, et al. Identification of a (CUG)n triplet repeat RNA·binding protein and its expression in myotonic dystrophy. Nucl Acids Res 1996; 24:4407-4414.
36. Philips AV, Timchenko LT, Cooper TA. Disruption of splicing regulated by a CUG-binding protein in myotonic dystrophy. Science 1998; 280:737-741.
37. Timchenko NA, Cai ZJ, Welm AL, et al. RNA CUG repeats sequester CUGBP1 and alter protein levels and activity of CUGBP1. J Biol Chem 2001; 276:7820-7826.
38. Savkur RS, Philips AV, Cooper TA. Aberrant regulation of insulin receptor alternative splicing is associated with insulin resistance in myotonic dystrophy. Nat Genet 2001; 29:40-47.
39. Timchenko NA, Iakova P, Cai ZJ, et al. Molecular basis for impaired muscle differentiation in myotonic dystrophy. Mol Cell Biol 2001; 21:6927-6938.
40. Michalowski S, Miller JW, Urbinati CR, et al. Visualization of double-stranded RNAs from the myotonic dystrophy protein kinase gene and interactions with CUG-binding protein. Nucl Acids Res 1999; 27:3534-3542.
41. Fardaei M, Larkin K, Brook JD, Hamshere MG. In vivo co-localisation of MBNL protein with DMPK expanded-repeat transcripts. Nucl Acids Res 2001; 29:2766-2771.
42. Miller JW, Urbinati CR, Teng-umnuay P, et al. Recruitment of human muscleblind proteins to (CUG)(n) expansions associated with myotonic dystrophy. EMBO J 2000; 19:4439-4448.
43. Mankodi A, Urbinati CR, Yuan QP, et al. Muscleblind localizes to nuclear foci of aberrant RNA in myotonic dystrophy types 1 and 2. Hum Mol Genet 2001; 10:2165-2170.
44. Fardaei M, Rogers MT, Thorpe HM, et al. Three proteins, MBNL, MBLL and MBXL, co-localize in vivo with nuclear foci of expanded-repeat transcripts in DM1 and DM2 cells. Hum Mol Genet 2002; 11:805-814.
45. Artero R, Prokop A, Paricio N, et al. The muscleblind gene participates in the organization of Z-bands and epidermal attachments of Drosophila muscles and is regulated by Dmef2. Dev Biology 1998; 195:131-143.
46. Yoshimura N, Otake M, Igarashi K, et al. Topography of Alzheimer's neurofibrillary change distribution in myotonic dystrophy. Clin Neuropathol 1990; 9:234-239.
47. Vermersch P, Sergeant N, Ruchoux MM, et al. Specific tau variants in the brains of patients with myotonic dystrophy. Neurology 1996; 47:711-717.
48. Sergeant N, Sablonniere B, Schraen-Maschke S, et al. Dysregulation of human brain microtubule-associated tau mRNA maturation in myotonic dystrophy type 1. Hum Mol Genet 2001; 10:2143-2155.
49. Furling D, Coiffier L, Mouly V, et al. Defective satellite cells in congenital myotonic dystrophy. Hum Mol Genet 2001; 10:2079-2087.
50. Khajavi M, Tari AM, Patel NB, et al. 'Mitotic drive' of expanded CTG repeats in myotonic dystrophy type 1 (DM1). Hum Mol Genet 2001; 10:855-863.
51. Amack JD, Paguio AP, Mahadevan MS. Cis and trans effects of the myotonic dystrophy (DM) mutation in a cell culture model. Hum Mol Genet 1999; 8:1975-1984.
52. Amack JD, Mahadevan MS. The myotonic dystrophy expanded CUG repeat tract is necessary but not sufficient to disrupt C2C12 myoblast differentiation. Hum Mol Genet 2001; 10:1879-1887.
53. Thornton CA, Griggs RC, Moxley RT. Myotonic dystrophy with no trinucleotide repeat expansion. Ann Neurol 1994; 35:269-272.
54. Ricker K, Koch MC, Lehmann-Horn F, et al. Proximal myotonic myopathy: a new dominant disorder with myotonia, muscle weakness, and cataracts. Neurology 1994; 44:1448-1452.
55. Udd B, Krahe R, Wallgrenpettersson C, et al. Proximal myotonic dystrophy - a family with autosomal dominant muscular dystrophy, cataracts, hearing loss, and hypogonadism - heterogeneity of proximal myotonic syndromes. Neuromusc Disord 1997; 7:217-228.
56. Day JW, Roelofs R, Leroy B, et al. Clinical and genetic characterization of a five-generation family with a novel form of myotonic dystrophy (DM2). Neuromusc Disord 1998; 9:19-27.
57. Ranum LP, Rasmussen PF, Benzow KA, et al. Genetic mapping of a second myotonic dystrophy locus. Nat Genet 1998; 19:196-198.
58. Ricker K, Grimm T, Koch MC, et al. Linkage to chromosome 3q in proximal myotonic myopathy (PROMM). Neurology 1998; 52:170-171.
59. Meola G, Sansone V, Marinou K, et al. Proximal myotonic myopathy: a syndrome with a favourable prognosis? J Neurol Sci 2002; 193:89-96.
60. Koch MC, Steinmeyer K, Lorenz C, et al. The skeletal muscle chloride channel in dominant and recessive human myotonia. Science 1992; 257:797-800.
61. Nagamitsu S, Matsuura T, Khajavi M, et al. A 'dystrophic' variant of autosomal recessive myotonia congenita caused by novel mutations in the CLCN1 gene. Neurology 2000; 55:1697-1703.
62. Dutzler R, Campbell EB, Cadene M, et al. X-ray structure of a CIC chloride channel at 3.0 A reveals the molecular basis of anion selectivity. Nature 2002; 415:287-294.
63. Wu FF, Takahashi MP, Pegoraro E, et al. A new mutation in a family with cold·aggravated myotonia disrupts Na(+) channel inactivation. Neurology 2001; 56:878-884.
64. Damian MS, Gerlach A, Schmidt F, et al. Modafinil for excessive daytime sleepiness in myotonic dystrophy. Neurology 2001; 56:794-796.